Localization of IFT proteins is perturbed in <i>Ttbk2</i> hypomorphic alleles. by Emily Bowie (543704)

Box and whisker plots of the VSD and VDI distribution in the tertiary referral centers (Cohort 1). by Sam Kushner-Lenhoff (12003804)

Supplementary Table 1 - Additional PSD Results by David Aguilar (7148330)

“…</b>Arrows represent a significant increase (↑) or decrease (↓) in normalized mGluR5 KO spectral power compared to WT controls in the same condition. …”

GFP-LL5β(381–510) inhibits tumor cell invasion. by Lucrezia Maria Ribolla (16535119)

“…(<b>D</b>) Clones of MDA-MB-231 cells expressing the indicated GFP-tagged proteins were used for transwell Matrigel invasion assays: invasion is significantly decreased for cells expressing GFP-LL5β(381–510), but not for cells expressing either GFP or GFP-LL5β(305–450). …”

Targeted quantification of Na⁺, Cl^-, S and Mg²⁺ in the cytosol, mitochondria, condensed chromatin and nucleoplasm. by Frédérique Nolin (2151472)

Targeted quantification of water and of N, P and K⁺ in the cytosol, mitochondria, condensed chromatin and nucleoplasm. by Frédérique Nolin (2151472)

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Exploiting the 2‑Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery by Pasquale Linciano (4426435)

“…In particular, compound <b>4m</b>, a biphenyl-thiadiazole-2,5-diamine with IC₅₀ = 16 μM, was able to potentiate the antitrypanosomal activity of the dihydrofolate reductase inhibitor methotrexate (MTX) with a 4.1-fold decrease of the EC₅₀ value. …”

Ciliary defects are evident in <i>Ttbk2</i> hypomorphic mutant cells. by Emily Bowie (543704)

Structure-function correlation of the central retina in a patient with X-linked retinoschisis (upper panels) and a patient with Usher syndrome 2A (lower panels). by Peter Charbel Issa (241475)

“…Only the most distinct alterations result in a relative scotoma (10 dB decreased light intensity compared to the brightest stimulus). …”

JMJD5 forms a complex with CRY1–FBXL3 and leads to CRY1 degradation. by Anand R. Saran (6034127)

“…(D) Knockdown of FBXL3 decreases JMJD5 co-IP with CRY1. Densitometric analysis showing ratio of JMJD5 to CRY1 signals from these experiments (mean ± SEM, <i>n</i> = 4) are shown in (E). …”

5-Choice Serial Reaction Time Task (5-CSRTT) Results Longitudinally for <i>Hdh</i>^{<i>Q111/+</i>} animals over 18 months of testing. by Emma Yhnell (3193398)

“…Data are shown for a total of 16 mice, 7 <i>Hdh</i>^{<i>Q111/+</i>} and 9 wild type and is the average number of responses made over 5 days of testing at each stimulus length. Error bars represent ± standard error of the mean. * p<0.05, ** p<0.01, *** p<0.001.…”

Effect of nF and mF fibroblasts on the phenotype of colonocytes. by Pascale Plaisancié (13531638)

RIPK1 activity is dispensable for <i>Yersinia</i>-induced extrinsic apoptosis in human macrophages. by Neha M. Nataraj (19485995)